Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.

Identifieur interne : 006055 ( Main/Exploration ); précédent : 006054; suivant : 006056

Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.

Auteurs : Yossef Kliger [Israël] ; Erez Y. Levanon

Source :

RBID : pubmed:14499001

Descripteurs français

English descriptors

Abstract

Severe acute respiratory syndrome (SARS) is a febrile respiratory illness. The disease has been etiologically linked to a novel coronavirus that has been named the SARS-associated coronavirus (SARS-CoV), whose genome was recently sequenced. Since it is a member of the Coronaviridae, its spike protein (S2) is believed to play a central role in viral entry by facilitating fusion between the viral and host cell membranes. The protein responsible for viral-induced membrane fusion of HIV-1 (gp41) differs in length, and has no sequence homology with S2.

DOI: 10.1186/1471-2180-3-20
PubMed: 14499001


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.</title>
<author>
<name sortKey="Kliger, Yossef" sort="Kliger, Yossef" uniqKey="Kliger Y" first="Yossef" last="Kliger">Yossef Kliger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Compugen LTD, Tel Aviv, 69512, Israel. kliger@compugen.co.il</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Compugen LTD, Tel Aviv, 69512</wicri:regionArea>
<wicri:noRegion>69512</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Levanon, Erez Y" sort="Levanon, Erez Y" uniqKey="Levanon E" first="Erez Y" last="Levanon">Erez Y. Levanon</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14499001</idno>
<idno type="pmid">14499001</idno>
<idno type="doi">10.1186/1471-2180-3-20</idno>
<idno type="wicri:Area/PubMed/Corpus">003182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003182</idno>
<idno type="wicri:Area/PubMed/Curation">003182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003182</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003299</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003299</idno>
<idno type="wicri:Area/Ncbi/Merge">000344</idno>
<idno type="wicri:Area/Ncbi/Curation">000344</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000344</idno>
<idno type="wicri:Area/Main/Merge">006555</idno>
<idno type="wicri:Area/Main/Curation">006055</idno>
<idno type="wicri:Area/Main/Exploration">006055</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.</title>
<author>
<name sortKey="Kliger, Yossef" sort="Kliger, Yossef" uniqKey="Kliger Y" first="Yossef" last="Kliger">Yossef Kliger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Compugen LTD, Tel Aviv, 69512, Israel. kliger@compugen.co.il</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Compugen LTD, Tel Aviv, 69512</wicri:regionArea>
<wicri:noRegion>69512</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Levanon, Erez Y" sort="Levanon, Erez Y" uniqKey="Levanon E" first="Erez Y" last="Levanon">Erez Y. Levanon</name>
</author>
</analytic>
<series>
<title level="j">BMC microbiology</title>
<idno type="eISSN">1471-2180</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-HIV Agents (pharmacology)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Drug Design</term>
<term>Enfuvirtide</term>
<term>HIV Envelope Protein gp41 (pharmacology)</term>
<term>HIV-1 (chemistry)</term>
<term>HIV-1 (drug effects)</term>
<term>Molecular Sequence Data</term>
<term>Peptide Fragments (pharmacology)</term>
<term>Protein Conformation</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (drug effects)</term>
<term>Viral Fusion Proteins (chemistry)</term>
<term>Viral Fusion Proteins (genetics)</term>
<term>Viral Fusion Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Agents antiVIH (pharmacologie)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Données de séquences moléculaires</term>
<term>Fragments peptidiques (pharmacologie)</term>
<term>Protéine d'enveloppe gp41 du VIH (pharmacologie)</term>
<term>Protéines de fusion virale ()</term>
<term>Protéines de fusion virale (génétique)</term>
<term>Protéines de fusion virale (métabolisme)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
<term>Virus du SRAS ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-HIV Agents</term>
<term>Antiviral Agents</term>
<term>HIV Envelope Protein gp41</term>
<term>Peptide Fragments</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>HIV-1</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>HIV-1</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Protéines de fusion virale</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Protéines de fusion virale</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Agents antiVIH</term>
<term>Antiviraux</term>
<term>Fragments peptidiques</term>
<term>Protéine d'enveloppe gp41 du VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Design</term>
<term>Enfuvirtide</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Données de séquences moléculaires</term>
<term>Protéines de fusion virale</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a febrile respiratory illness. The disease has been etiologically linked to a novel coronavirus that has been named the SARS-associated coronavirus (SARS-CoV), whose genome was recently sequenced. Since it is a member of the Coronaviridae, its spike protein (S2) is believed to play a central role in viral entry by facilitating fusion between the viral and host cell membranes. The protein responsible for viral-induced membrane fusion of HIV-1 (gp41) differs in length, and has no sequence homology with S2.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Israël</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Levanon, Erez Y" sort="Levanon, Erez Y" uniqKey="Levanon E" first="Erez Y" last="Levanon">Erez Y. Levanon</name>
</noCountry>
<country name="Israël">
<noRegion>
<name sortKey="Kliger, Yossef" sort="Kliger, Yossef" uniqKey="Kliger Y" first="Yossef" last="Kliger">Yossef Kliger</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006055 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006055 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:14499001
   |texte=   Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:14499001" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021